Literature DB >> 10710586

Joint British recommendations on prevention of coronary heart disease in clinical practice: summary. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, British Diabetic Association.

.   

Abstract

Entities:  

Mesh:

Year:  2000        PMID: 10710586      PMCID: PMC1117715          DOI: 10.1136/bmj.320.7236.705

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  38 in total

Review 1.  Management of diabetic nephropathy.

Authors:  L Foggensteiner; S Mulroy; J Firth
Journal:  J R Soc Med       Date:  2001-05       Impact factor: 5.344

2.  Screening for cardiovascular risk: public health imperative or matter for individual informed choice?

Authors:  Theresa M Marteau; Ann Louise Kinmonth
Journal:  BMJ       Date:  2002-07-13

3.  The role of evidence in health policy making: a normative perspective.

Authors:  Ole Frithjof Norheim
Journal:  Health Care Anal       Date:  2002

4.  Guidelines on preventing cardiovascular disease in clinical practice.

Authors:  R Jackson
Journal:  BMJ       Date:  2000-03-11

Review 5.  Aspirin for everyone older than 50? For.

Authors:  Peter Elwood; Gareth Morgan; Ginevra Brown; Janet Pickering
Journal:  BMJ       Date:  2005-06-18

Review 6.  The implications of a growing evidence base for drug use in elderly patients. Part 1. Statins for primary and secondary cardiovascular prevention.

Authors:  A A Mangoni; S H D Jackson
Journal:  Br J Clin Pharmacol       Date:  2006-05       Impact factor: 4.335

7.  Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetes.

Authors:  R N Guzder; W Gatling; M A Mullee; C D Byrne
Journal:  Diabetologia       Date:  2005-12-10       Impact factor: 10.122

Review 8.  Framingham-based tools to calculate the global risk of coronary heart disease: a systematic review of tools for clinicians.

Authors:  Stacey Sheridan; Michael Pignone; Cynthia Mulrow
Journal:  J Gen Intern Med       Date:  2003-12       Impact factor: 5.128

Review 9.  Novel risk factors for cardiovascular disease in rheumatoid arthritis.

Authors:  Jenny Amaya-Amaya; Juan Camilo Sarmiento-Monroy; Ruben-Dario Mantilla; Ricardo Pineda-Tamayo; Adriana Rojas-Villarraga; Juan-Manuel Anaya
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

Review 10.  Prolonged-release nicotinic acid: a review of its use in the treatment of dyslipidaemia.

Authors:  Paul L McCormack; Gillian M Keating
Journal:  Drugs       Date:  2005       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.